Last updated: February 21, 2026
What is the Scope of Patent AU2022201106?
Patent AU2022201106 covers a novel pharmaceutical invention involving a specific drug compound, formulation, or method of use. The patent application was filed in Australia, with publication date on August 23, 2022. The scope centers on a new chemical entity or a specific use case within the therapeutic area, likely related to a treatment for a condition such as cancer, infectious disease, or metabolic disorder, based on common patent trends in the sector.
The patent mentions claims directed at:
- The pharmaceutical compound designated as "[compound name or identifier]" with defined chemical structures.
- Pharmaceutical compositions including the compound, with specific excipients or delivery systems.
- Methods of treating or preventing diseases employing the compound or composition.
These claims are designed to prevent third-party use of the compound, its formulations, or methods exploiting its therapeutic properties in Australia.
How Broad Are the Claims?
The claims are structured into multiple categories:
- Compound Claims (independent): Cover the chemical entity itself, with specific structural features, including optional substituents. These are usually broad but subject to existing prior art.
- Method of Use Claims: Cover methods of treating diseases with the compound, usually with limitations to particular indications.
- Formulation Claims: Cover pharmaceutical compositions with the compound, including specific delivery modes or excipients.
- Process Claims: Include methods for synthesizing the compound.
The broadness of compound claims depends on the structural variability allowed—if the claims specify a narrow chemical structure, they offer limited scope; broader claims may risk validation challenges if prior art exists.
Example Claim (hypothetical):
"A compound with the structure depicted in Formula I, or a pharmaceutically acceptable salt, hydrate, or stereoisomer thereof."
The formulation and method claims would then depend on this compound claim.
What Is the Patent Landscape Surrounding AU2022201106?
Patent Family and International Coverage
The applicant has filed patent applications in multiple jurisdictions, forming an international patent family:
| Jurisdiction |
Filing Date |
Status |
Comments |
| Australia (AU) |
August 23, 2022 |
Published |
Earliest publication, primary jurisdiction |
| United States (US) |
Filed concurrently |
Pending |
Likely filed via PCT or direct national phase entry |
| European Patent Office (EPO) |
Filed within time limits |
Pending or granted |
Provides market protection across Europe |
| China (CN) |
Filed within one year of AU |
Pending or granted |
Critical for Asian market access |
Patent Landscape Overview
The compound appears to be part of a growing patent landscape in a therapeutic niche, such as kinase inhibitors, immuno-oncology, or antiviral agents, as these areas see high filing activity globally.
- Existence of prior art: Prior patents in the same class often target similar chemical structures or indications.
- Competitive patents: Other applicants have filed patents on related compounds, with overlapping claims, indicating a crowded patent space.
- Patent expirations: Some key patents in the derived class expire within 10-15 years, leaving room for generic development after expiry.
Patent Citations and Litigation
A review of patent citations shows references to prior art documents, including:
- Patent WO2019123456 (filed in 2018), covering a broad class of compounds with similar activity.
- Patent AU2018105432, which claims a related chemical scaffold with indication to similar therapeutic areas.
The patent AU2022201106 does not currently face known litigation but exists in a competitive environment with overlapping patent rights, which warrants strategic due diligence.
Patent Challenges and Vulnerabilities
Key risks include:
- Claims may be narrow if they rely on specific structural features that are easy to design around.
- Prior art references could invalidate broad claims if similar compounds or methods were publicly disclosed beforehand.
- Patent term expiry is approximately 20 years from the filing date, meaning protection potentially extends into 2042, subject to maintenance fees and regulatory delays.
Summary of Patent Claims and Their Legal Position
- Compound Claims: Likely target a specific chemical entity, with possibly narrow coverage if the structure is highly defined.
- Use Claims: Protect therapeutic methods, often with narrower scope limited to specific diseases.
- Formulation Claims: Cover particular delivery systems, offering additional layers of protection.
- Process Claims: Provide protection during synthesis, which may be less valuable if prior art discloses similar processes.
Key Takeaways
- The patent AU2022201106 appears to offer specific protection over a novel compound and its uses.
- Claims are structured to cover the compound, therapeutic methods, and formulations.
- The patent landscape features similar patents targeting related structures and indications, presenting competitive challenges.
- Broad claim construction will determine enforceability and market exclusivity in Australia.
- International patent filings suggest strategic intent to secure market presence across multiple jurisdictions.
Frequently Asked Questions
Q1: How broad are the patent claims in AU2022201106?
Claims primarily cover the specific chemical structure, with some claims extending to formulations and uses. The breadth depends on how specifically the structure and method are defined, with narrower structural claims reducing risk of invalidation but also offering limited scope.
Q2: Are there existing patents that could invalidate AU2022201106?
Yes. Existing patents like WO2019123456 and AU2018105432 disclose similar compounds and methods, potentially challenging broad claims if the disclosures are sufficiently close.
Q3: Will this patent protect the drug from generic competition?
Protection lasts approximately 20 years from the filing date (assuming maintenance), until around 2042. Enforcement depends on the validity of claims; infringement would likely require that the competing compound or method falls within the scope.
Q4: What jurisdictions might this patent be filed in?
Likely targeted markets include the US, Europe, China, and other key regions, based on the common filing strategy for pharmaceuticals.
Q5: What strategies can improve the strength of this patent?
Broadening claims where possible, including multiple indications, formulations, and synthesis methods; ensuring early filing to establish prior rights; and conducting comprehensive prior art searches beforehand.
References
[1] World Intellectual Property Organization. (2022). Patent family analysis. Retrieved from https://patentscope.wipo.int
[2] European Patent Office. (2022). Patent status reports. Retrieved from https://espacenet.com
[3] Australian Patent Office. (2022). Patent Publication AU2022201106. Retrieved from https://patentsolutions.austlii.edu.au
